Problems and perspectives in the treatment of respiratory infections caused by atypical pathogens

Pulm Pharmacol Ther. 2001;14(1):21-7. doi: 10.1006/pupt.2000.0270.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Chlamydia / pathogenicity
  • Chlamydia / physiology
  • Chlamydia Infections / drug therapy*
  • Chlamydia Infections / pathology
  • Humans
  • Legionella / pathogenicity
  • Legionellosis / drug therapy
  • Legionellosis / microbiology
  • Legionellosis / pathology
  • Mycoplasma Infections / drug therapy*
  • Mycoplasma Infections / microbiology*
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / microbiology*

Substances

  • Anti-Bacterial Agents